← Back to Search

Behavioural Intervention

Intervention for Type 2 Diabetes (CRX-T2D Trial)

N/A
Waitlist Available
Led By Sujay Madduri, MD
Research Sponsored by QuiO
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 120
Awards & highlights

CRX-T2D Trial Summary

This study is evaluating whether a new technology may help improve diabetes management.

Eligible Conditions
  • Type 2 Diabetes

CRX-T2D Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 120
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 120 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in HbA1c
Secondary outcome measures
Fasting Blood Glucose
Mean Duration of Time to Reach Optimal Insulin Glargine Dose
Median Adherence to Insulin Glargine
+2 more

CRX-T2D Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment2 Interventions
Subjects in the Intervention arm will receive the following: Automated in-app messages containing behavioral and educational content that is tailored to each subject based on an assessment of their entry survey results and on their adherence and glucose data. (Behavioral Support Engine). Targeted in-app messages and phone calls from clinicians or as designated by the Investigator (through the CRx Care app) based on the subject's adherence and glucose data. Push notifications that alert the subject that it is time to complete a regimen event (ie take medication or take a fasting blood glucose reading). Push notifications that alert the subject that they have missed a scheduled regimen event. In-app messages containing adjustments to the subject's insulin glargine dose when the Investigator(s) approves an adjustment in the CRx Care App. (Treatment Support Engine).
Group II: ControlActive Control1 Intervention
Subjects in the Control arm will receive the CRx Health solution for self-management of chronic conditions.

Find a Location

Who is running the clinical trial?

QuiOLead Sponsor
SHL MedicalUNKNOWN
MidMichigan HealthUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Chronicare for Type 2 Diabetes (Chronicare-T2D)
2020. "Chronicare for Type 2 Diabetes (Chronicare-T2D)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03997331.
All > Type 2 Diabetes
~20 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top